Dufry has successfully closed the transfer of the 50.3% stake in Autogrill held by Edizione through a wholly owned subsidiary to Dufry. Dufry will launch a mandatory public exchange offer for the remaining Autogrill shares (excluding
Tags :Frank Gerhard
DKSH Holding will sell its 25% stake in Swiss luxury watchmaker Bovet to Pascal Raffy which makes him the watchmaker’s sole owner due that he owns already the 75% of Bovet Fleurier. Raffy, a former pharmaceutical
LatticeFLow, an ETH spin-off pioneering in robust artificial intelligence (AI) having built a system that can automatically find and fix AI data and model errors, announced a USD 12 m Series A funding round led by
PHOENIX Pharma Switzerland, a subsidiary of the family-owned PHOENIX group, and Voigt Holding announced that they agreed to establish a 50/50-joint venture to combine their pharmaceutical distribution services and pre-wholesale activities. The closing of the
DKSH Holding has acquired Terra Firma, a leading distributor of specialty chemicals in North America. With this acquisition, DKSH expands its performance materials business unit platform to the US and Canada. The transaction is an
Addex Therapeutics, a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery and development, has completed a USD 4,2 million equity financing. The allosteric modulation company Addex has entered into a definitive agreement with Armistice Capital, a
BlackFin Capital Partners has reported the sale of its portfolio company New Access, a Geneva-based private banking technology firm, to FNZ, a global wealth management platform with registered office in London. The acquisted New Access
Dufry has announced that it has entered into an agreement with the Italian company Edizione to collaborate with Autogrill to create a new integrated global travel experience. The combined company will serve more than 2.3 billion
DKSH Holding has announced the acquisition of Swiss Refarmed Group, strengthening its capabilities in the life sciences. Through the acquisition, DKSH Business Unit Performance Materials, the leading global distributor of innovative pharmaceutical ingredients synthesis and
Clariant has completed the sale of its pigments business to a consortium of Heubach Group and SK Capital Partners and reinvested approx. CHF 115 million of the purchase price to become a 20% shareholder alongside Heubach Group
